Ignite Creation Date:
2025-12-24 @ 12:24 PM
Ignite Modification Date:
2026-01-01 @ 5:10 PM
Study NCT ID:
NCT01895361
Status:
COMPLETED
Last Update Posted:
2020-01-31
First Post:
2013-07-03
Is NOT Gene Therapy:
True
Has Adverse Events:
True
Brief Title:
Study to Assess Safety and Impact of SelG1 With or Without Hydroxyurea Therapy in Sickle Cell Disease Patients With Pain Crises
Sponsor:
Reprixys Pharmaceutical Corporation
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2013-07
Start Date Type:
None
Primary Completion Date:
2016-03
Primary Completion Date Type:
ACTUAL
Completion Date:
2016-03
Completion Date Type:
ACTUAL
First Submit Date:
2013-07-03
First Submit QC Date:
None
Study First Post Date:
2013-07-10
Study First Post Date Type:
ESTIMATED
Results First Submit Date:
2019-12-12
Results First Submit QC Date:
None
Results First Post Date:
2020-01-31
Results First Post Date Type:
ACTUAL
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2020-01-21
Last Update Post Date:
2020-01-31
Last Update Post Date Type:
ACTUAL